News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RheoGene, Inc. And TissueGene Inc. Sign Collaborative Agreement For Bone Regeneration And Repair



10/19/2005 5:13:13 PM

NORRISTOWN, PA -- (MARKET WIRE) -- 04/19/2005 -- RheoGene Inc. and TissueGene Inc. (Gaithersburg, MD) have entered into a collaborative research and licensing agreement to develop regulated cell therapy treatments for bone restoration and repair. The companies will combine TissueGene's patented cell therapy technology and RheoGene's proprietary RheoSwitch Therapeutic System (RTS) to develop non-surgical treatments for non-union bone fractures, non-healing bone wounds and osteoporosis.

Read at Market Wired


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES